GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corestemchemon Inc (XKRX:166480) » Definitions » Market Cap

Corestemchemon (XKRX:166480) Market Cap : ₩300,950 Mil (As of Dec. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Corestemchemon Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Corestemchemon's share price for the quarter that ended in Sep. 2024 was ₩11980. Corestemchemon's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 24 Mil. Therefore, Corestemchemon's market cap for the quarter that ended in Sep. 2024 was ₩291,834 Mil.

Corestemchemon's quarterly market cap increased from Mar. 2024 (₩237,068 Mil) to Jun. 2024 (₩290,679 Mil) and increased from Jun. 2024 (₩290,679 Mil) to Sep. 2024 (₩291,834 Mil).

Corestemchemon's annual market cap declined from Dec. 2021 (₩293,575 Mil) to Dec. 2022 (₩166,356 Mil) and declined from Dec. 2022 (₩166,356 Mil) to Dec. 2023 (₩144,943 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Corestemchemon's Enterprise Value for Today is ₩339,545 Mil.


Corestemchemon Market Cap Historical Data

The historical data trend for Corestemchemon's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corestemchemon Market Cap Chart

Corestemchemon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 142,242.47 364,643.68 293,574.65 166,355.70 144,942.99

Corestemchemon Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 135,311.20 144,942.99 237,068.17 290,678.57 291,834.00

Competitive Comparison of Corestemchemon's Market Cap

For the Biotechnology subindustry, Corestemchemon's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Corestemchemon's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Corestemchemon's Market Cap distribution charts can be found below:

* The bar in red indicates where Corestemchemon's Market Cap falls into.



Corestemchemon Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Corestemchemon's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=₩6770*21.4096
=₩144,943

Corestemchemon's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=₩11980*24.3601
=₩291,834

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Corestemchemon  (XKRX:166480) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Corestemchemon Market Cap Related Terms

Thank you for viewing the detailed overview of Corestemchemon's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Corestemchemon Business Description

Traded in Other Exchanges
N/A
Address
Pangyo 255 beongil 24 I & C Building, 2nd Floor, yeonggi-do, Bundang-gu, Seongnam, Seoul, KOR, 13486
Corestemchemon Inc is a biopharmaceutical company that researches and commercializes stem cell technology. It has developed NEURONATA-R inj., a stem cell therapy for Lou Gehrig's disease which is a rare incurable disease, for the first ALS treatment. Its stem cell therapeutics for Lou Gehrig's disease have a pipeline of incurable diseases such as lupus, multiple system atrophy, and osteoarthritis, and plans to preoccupy the market by focusing on developing therapies for rare incurable diseases based on a development success reference of stem cell therapy for the Lou Gehrig's disease.

Corestemchemon Headlines

No Headlines